One of your best @otherperspective. And as always, presented in a clear and simple way for many of us laypersons to understand.
If you have time could you very briefly expand on what approximate % differential figure ( control v treatment) of reductions in MACE , you imagine would fit each category?
For eg:
1. Overwhelming efficiency (40%-100%)
2. Confirmation trial required. (15%- 40% )
3. Fail. ( 0-15%)
* I have no idea
Also do you still hold hope for Feb Headline results if permitted?
MSB Trading - 2020, page-297
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |